Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.5 was added, replacing the previous v3.6.4 revision. This appears to be a small internal update to the page template or rendering, not a change to study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label was updated to Revision: v3.6.4, signaling a new version of the page for the study record. This update is limited to metadata and does not alter study details or other visible content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page footer now shows Revision: v3.6.3 instead of v3.6.2. This is a minor maintenance update to the page's versioning information, with no changes to study content or functionality.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version was deployed. No user-facing content changes are indicated by the data.SummaryDifference0.1%

- Check60 days agoChange DetectedRecruitment status now indicates no longer looking for participants, signaling that enrollment is closed or paused. New helper sections were added (How to Read a Study Record, Common Questions, How to Join a Study) alongside a revised Intervention/Treatment section and a v3.6.0 site revision note.SummaryDifference0.5%

- Check68 days agoChange Detected- The page's revision label updated from v3.5.4 to v3.5.5, indicating a new build/version of the page. - The previous revision label has been replaced by the new one, reflecting an incremental update to the site.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.